The week started out relatively quietly, with the major indexes basically meandering sideways through Wednesday, even after the Federal Reserve’s statement. But since Thursday morning, things have been whipping around (mostly on the upside) as it appears a U.S.-China trade deal/truce is at hand.
Read More
One of the portfolio stocks reports good fourth-quarter results.
Read More
The upward trajectory for growth stocks that was smooth sailing in November has turned far bumpier in December.
Read More
From Cabot Top Ten Trader
Near-term, some wobbles are possible, but overall we think the market’s likely to head higher over time. Individual stocks have been trickier—some look great and are racing to new highs, but the past couple of weeks have also revealed potholes,...
Read More
Remain bullish, while keep your eyes open as some stocks have hit potholes. The market itself is in good shape, though we continue to think some news-driven ups and downs are likely in the near term.
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Term preferred stocks and baby bonds offer some of the best fixed-rate bonds to buy on today's market. And right now, four of them stand out.
Read More
Here we are within weeks of the end of year and the end of a decade. It is approaching the 11th year of the recovery and bull market. The S&P 500 is up 25% in 2019 and very near the all-time high. Where we...
Read More
Especially with small caps, it’s not always an efficient market in the short-term. So sometimes the best thing to do is nothing. Just sit back and think it over.
Read More
The good news is that 2019, which started off so well for the cannabis sector but is ending so poorly, is nearing the finish line. The bad news is that we still have three weeks to go, technically, though many of those days see...
Read More
Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction.
Read More
One of the portfolio stocks reported third-quarter results.
Read More
The market remains in a normal consolidation phase, and most of our stocks look fine.
Read More
A high percentage of stocks that I follow are exhibiting bullish price charts right now. Obviously, you already knew that the stock market has been acting well. I simply want to reiterate that the recent bullishness appears to be sustainable. Enjoy!
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
The Big Idea
How psyched would you be if you went to your healthcare provider and they said the following:
“I can make a health optimization recommendation for you, informed not only by the latest clinical trials, but also by local and regional data about like...
Read More
Crista continues to believe this stock is greatly undervalued.
Read More
Profit taking finally set in earlier this week, though this morning’s jobs-inspired pop has erased the losses for the major indexes.
Read More
A Normal Breather
As the market pushed sharply higher following its early-October low (10% or so in the S&P 500, 12%-plus in the Nasdaq), rising seven out of eight weeks, the worries of the world (trade wars, slowing economic growth, even impeachment) were slowly As...
Read More